Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenofovir vs Lamivudine in Chronic Hepatitis B with Severe Acute Exacerbation
NCT01848743Phase 3Unknown
- Sponsor
- Kaohsiung Veterans General Hospital
- Start
- Apr 2013
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tenofovir in Chronic Hepatitis B (CHB), sponsored by Kaohsiung Veterans General Hospital. Status: unknown.
02
Drugs
tenofovir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT01848743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01848743.